We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+14.84%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$65.3B
AUM Growth
+$7.1B
Cap. Flow
-$1.98B
Cap. Flow %
-3.04%
Top 10 Hldgs %
42.82%
Holding
1,073
New
165
Increased
251
Reduced
511
Closed
103

Sector Composition

Rank Sector Weight
1 Technology 26.98%
2 Communication Services 16.8%
3 Consumer Discretionary 15.29%
4 Healthcare 13.27%
5 Financials 10.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTSI icon
76
MACOM Technology Solutions
MTSI
$23.7B
$77.7M 0.12%
835,427
-26,451
-3% -$2.18M
ARM icon
77
Arm
ARM
$302B
$77.5M 0.12%
1,031,843
-33,241
-3% -$1.94M
SITE icon
78
SiteOne Landscape Supply
SITE
$4.53B
$76.1M 0.12%
468,353
-9,745
-2% -$1.42M
SMPL icon
79
Simply Good Foods
SMPL
$982M
$74.2M 0.11%
1,873,365
+270,911
+17% +$10.1M
DOCS icon
80
Doximity
DOCS
$4.88B
$73.7M 0.11%
2,629,119
-57,747
-2% -$1.36M
ATI icon
81
ATI
ATI
$31B
$72.3M 0.11%
1,590,068
+870,450
+121% +$36.1M
INSM icon
82
Insmed
INSM
$28.6B
$72.3M 0.11%
2,331,505
-51,534
-2% -$1.34M
WK icon
83
Workiva
WK
$3.54B
$71.2M 0.11%
701,008
+17,590
+3% +$1.7M
BRBR icon
84
BellRing Brands
BRBR
$1.34B
$70.5M 0.11%
1,272,497
-611,212
-32% -$29.5M
AIN icon
85
Albany International
AIN
$1.78B
$67.5M 0.1%
687,624
-30,100
-4% -$2.63M
SLAB icon
86
Silicon Laboratories
SLAB
$7.23B
$67.5M 0.1%
510,349
-11,389
-2% -$1.25M
CRSP icon
87
CRISPR Therapeutics
CRSP
$5.17B
$66.8M 0.1%
1,067,351
-29,003
-3% -$1.6M
EVH icon
88
Evolent Health
EVH
$447M
$65.9M 0.1%
1,995,612
-49,001
-2% -$1.39M
KBR icon
89
KBR
KBR
$4.8B
$65.9M 0.1%
1,188,932
-388,977
-25% -$21.5M
WSC icon
90
WillScot Mobile Mini Holdings
WSC
$4.41B
$64.3M 0.1%
1,446,000
+65,297
+5% +$2.64M
CWST icon
91
Casella Waste Systems
CWST
$5.69B
$63.9M 0.1%
748,028
-23,683
-3% -$1.9M
IBP icon
92
Installed Building Products
IBP
$6.49B
$63.7M 0.1%
348,199
-11,024
-3% -$1.55M
FCN icon
93
FTI Consulting
FCN
$4.18B
$63.3M 0.1%
317,736
-37,043
-10% -$7.66M
VRNS icon
94
Varonis Systems
VRNS
$5B
$62.5M 0.1%
1,380,544
-43,704
-3% -$1.64M
ACHC icon
95
Acadia Healthcare
ACHC
$2.94B
$61.8M 0.09%
794,672
+21,077
+3% +$1.56M
MGRC icon
96
McGrath RentCorp
MGRC
$2.92B
$61.5M 0.09%
514,314
-65,791
-11% -$6.84M
WEX icon
97
WEX
WEX
$6.31B
$61.1M 0.09%
314,290
+53,384
+20% +$9.68M
CHDN icon
98
Churchill Downs
CHDN
$6.12B
$59.7M 0.09%
442,789
-12,972
-3% -$1.54M
NE icon
99
Noble Corp
NE
$6.51B
$59.6M 0.09%
1,237,449
-207,271
-14% -$9.69M
MGY icon
100
Magnolia Oil & Gas
MGY
$5.94B
$58.9M 0.09%
2,767,080
-55,272
-2% -$1.21M

Similar funds

Loomis, Sayles & Company's Q4 2023 Portfolio in Review

As of Q4 2023, Loomis, Sayles & Company held 1,073 positions worth $65.3B, up 12% from $58.2B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Loomis, Sayles & Company withdrew a net $1.98B in Q4 2023, closing 103 positions and reducing 511 holdings. Its most notable exit was Zions Bancorporation, an estimated $86.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Loomis, Sayles & Company opened a new position in Vertex worth $37.3M.

  • Loomis, Sayles & Company's largest Q4 2023 buy was Vertex: 1,383,755 shares worth $37.3M.
  • Loomis, Sayles & Company added most to O'Reilly Automotive in Q4 2023, an estimated $103M increase.
  • Loomis, Sayles & Company's biggest Q4 2023 reduction was Bank of America Series L, cutting an estimated $766M.
  • Loomis, Sayles & Company fully exited Zions Bancorporation in Q4 2023, selling an estimated $86.6M.
  • Loomis, Sayles & Company's ten largest holdings make up 43% of its $65.3B portfolio in Q4 2023.
  • Loomis, Sayles & Company opened 165 new positions and closed 103 in Q4 2023.
  • Loomis, Sayles & Company's portfolio value rose 12% quarter-over-quarter to $65.3B.

Based on Loomis, Sayles & Company's 13F filing for Q4 2023, filed 13 Feb 2024.